NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling

Mario Palma1, Elizabeth Riffo2, Alejandro Farias2

  • 1Laboratorio de Transducción de Señales y Cáncer, Departamento de Bioquímica y Biología Molecular, Facultad Cs. Biológicas, Universidad de Concepción, Concepción, Chile. mpalma@hsph.harvard.edu.

Cell & Bioscience
|December 22, 2023
PubMed
Abstract

Insights

NUAK1 kinase regulates growth factor-activated Akt signaling by controlling mTORC2 localization and directly phosphorylating Akt. Targeting NUAK1 may treat cancers with hyperactivated Akt signaling.

Area of Science:

  • Cellular Biology
  • Molecular Oncology

Background:

  • The mechanistic target of rapamycin complex 2 (mTORC2) pathway is crucial for cell growth, survival, and cytoskeletal organization.
  • While mTORC2 activates Akt kinase, the precise mechanisms regulating Akt activity and its crosstalk with other signaling pathways upon growth factor stimulation remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of NUAK1 in regulating growth factor-dependent Akt activation and signaling.
  • To investigate the molecular mechanisms by which NUAK1 influences Akt activity and downstream targets.
  • To assess the therapeutic potential of targeting NUAK1 in cancer.

Main Methods:

  • Investigated NUAK1's interaction with mTORC2 components and its effect on mTOR localization.
  • Assessed NUAK1's direct phosphorylation of Akt at Ser-473.
  • Analyzed the impact of NUAK1 on specific Akt substrates like FOXO1/3a and TSC2.
  • Examined NUAK1's subcellular localization using cell imaging techniques.
  • Evaluated the role of the NUAK1-Akt axis in regulating gene expression and cancer cell survival upon epidermal growth factor receptor (EGFR) stimulation.
  • Tested the efficacy of pharmacological inhibition of NUAK1 alone and in combination with Akt or mTOR inhibitors.
  • Correlated NUAK1 expression with EGFR and Akt phosphorylation in human cancer tissues.

Main Results:

  • NUAK1 regulates growth factor-dependent Akt activation through two mechanisms: controlling mTORC2 localization and directly phosphorylating Akt at Ser-473.
  • NUAK1 specifically phosphorylates Akt substrates FOXO1/3a but not TSC2, correlating with its association with early endosomes.
  • The NUAK1-Akt/FOXO1/3a axis regulates the expression of p21CIP1, p27KIP1, and FoxM1, impacting cancer cell survival upon EGFR stimulation.
  • Pharmacological inhibition of NUAK1 enhanced cell death induced by Akt or mTOR inhibitors.
  • NUAK1 expression positively correlates with EGFR expression and Akt Ser-473 phosphorylation in human cancers.

Conclusions:

  • NUAK1 kinase controls mTOR subcellular localization and directly induces Akt phosphorylation, thereby regulating growth factor-dependent Akt signaling.
  • Targeting NUAK1, alone or in combination with Akt or mTOR inhibitors, presents a potential therapeutic strategy for cancers exhibiting hyperactivated Akt signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K